Alarmins and central nervous system inflammation in HIV‐associated neurological disorders
Author:
- 16 November 2016
- journal article
- review article
- Published by Wiley in Journal of Internal Medicine
- Vol. 281 (5) , 433-447
Abstract
In the era of highly active antiretroviral therapy (HAART), HIV‐1‐associated neurocognitive disorders (HAND) persist in infected individuals with adequate immunological and virological status. Risk factors for cognitive impairment include hepatitis C virus co‐infection, host genetic factors predisposing to HAND, the early establishment of the virus in the CNS and its persistence under HAART; thus, the CNS is an important reservoir for HIV. Microglial cells are permissive to HIV‐1, and NLRP3 inflammasome‐associated genes were found expressed in brains of HIV‐1‐infected persons, contributing to brain disease. Inflammasomes can be triggered by alarmins or danger‐associated molecular patterns (DAMPs), which directly stimulate the production of proinflammatory mediators by glial cells, contribute to blood–brain barrier injury through induction of release of various proteases and allow the passage of infected macrophages, and trigger IL‐1β release from primed cells. Amongst alarmins involved in HIV‐1‐induced neuropathogenesis, IL‐33 and high‐mobility group box 1 (HMGB1) are of particular interest. Neurocognitive alterations were recently associated with dysregulation of the IL‐33/ST2 axis in the CNS, leading to the induction of neuronal apoptosis, decrease in synaptic function and neuroinflammation. Specific biomarkers, including HMGB1 and anti‐HMGB1 antibodies, have been identified in cerebrospinal fluid from patients with HAND, correlated with immune activation and identifying a very early stage of neurocognitive impairment that precedes changes in metabolites detected by magnetic resonance spectroscopy. Moreover, HMGB1 plays a crucial role in HIV‐1 persistence in dendritic cells and in the constitution of viral reservoirs. In this review, the mechanisms whereby alarmins contribute to HIV‐1‐induced CNS inflammation and neuropathogenesis will be discussed.Keywords
This publication has 138 references indexed in Scilit:
- Failure to clear intra-monocyte HIV infection linked to persistent neuropsychological testing impairment after first-line combined antiretroviral therapyJournal of NeuroVirology, 2011
- HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cellsCell Death & Differentiation, 2011
- Recently Infiltrating MAC387+ Monocytes/MacrophagesThe American Journal of Pathology, 2011
- Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individualsJournal of NeuroVirology, 2011
- Sterile inflammation: sensing and reacting to damageNature Reviews Immunology, 2010
- Mutant superoxide dismutase 1-induced IL-1β accelerates ALS pathogenesisProceedings of the National Academy of Sciences, 2010
- Human immunodeficiency virus‐associated neurocognitive disorders: Mind the gapAnnals of Neurology, 2010
- The NALP3 inflammasome is involved in the innate immune response to amyloid-βNature Immunology, 2008
- IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factorin vivoProceedings of the National Academy of Sciences, 2007
- Pathogen Recognition and Innate ImmunityCell, 2006